Heartstream Launched as Independent Emergency Care Company
Former Philips Emergency Care business becomes first platform company of Emergency Care Holdings, advancing a century-long mission to save lives BOTHELL, Wash., Jan. 15, 2026 /PRNewswire/ -- Emergency Care Holdings (ECH), a platform formed by Bridgefield Capital to assemble and grow category-leading companies in the emergency medical products sectors, announced the debut...
Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion
SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Yuyu Bio and Mervyn's Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on the UCLA campus, strengthening the company's presence in the United States pet and animal health market. The two companies are now based at Magnify, the startup incubator housed...
Metabolon Appoints Celia Reyes as Vice President of Human Resources
Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace MORRISVILLE, N.C., Jan. 14, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announces...
NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF
NEW YORK, Jan. 14, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins...
iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded pediatric use of its iotaSOFT® Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted...
Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences
LOS GATOS, Calif., Jan. 14, 2026 /PRNewswire/ -- Lynx Analytics today announced Lumen, a specialized Agentic AI framework designed to help pharmaceutical and biotech organizations generate strategic, decision-ready insights from complex scientific and commercial information. Built specifically for life sciences workflows, Lumen enables companies to deploy AI agents across a wide range of...
Head-to-Head Real-World Data: Cadonilimab Outperforms PD-1 Inhibitors in First-Line PD-L1-Low Gastric Cancer
HONG KONG, Jan. 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), comparing cadonilimab plus chemotherapy against a PD-1 inhibitor plus chemotherapy for the first-line (1L) treatment for advanced gastric (G) or gastroesophageal junction (GEJ) cancer with PD-L1 CPS <5 (a propensity-matched,...
Enhanced Genetype colorectal cancer risk test released – supports earlier disease detection and ColoSTAT® targeting
MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ -- Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer (CRC) Risk Assessment clinical test ("geneTypeTM CRC"), a significant advancement in personalised cancer risk prediction....
Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference
Celltrion outlines a blueprint for innovative drug development built on its antibody expertise The company highlights its business strategy to scale U.S. manufacturing and R&D capabilities, strengthening its global supply chain, production and operations INCHEON, South Korea, Jan. 14, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company,...
Teoxane to Launch First APAC Regional Academy in Bangkok
New hub strengthens Teoxane's commitment to scientific education and clinical partnerships across Asia-Pacific GENEVA, Jan. 14, 2026 /PRNewswire/ -- Teoxane opens its first APAC Regional Academy in Bangkok, Thailand this January, expanding its global medical-education network. Located on Level 12 of One Bangkok Tower 4, the hub offers a modern environment designed to...
